Aspiriant LLC’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Sell
35,362
-4,418
-11% -$260K 0.06% 108
2025
Q4
$2.18M Buy
39,780
+204
+0.5% +$11.1K 0.06% 101
2025
Q3
$2.11M Sell
39,576
-49,150
-55% -$2.47M 0.06% 98
2025
Q2
$4.28M Buy
88,726
+44,407
+100% +$2M 0.14% 69
2025
Q1
$1.94M Sell
44,319
-911
-2% -$39.6K 0.07% 97
2024
Q4
$1.89M Sell
45,230
-1,180
-3% -$52.3K 0.07% 98
2024
Q3
$2.13M Sell
46,410
-898
-2% -$38.7K 0.08% 94
2024
Q2
$2.01M Sell
47,308
-10,035
-17% -$421K 0.08% 90
2024
Q1
$2.36M Sell
57,343
-13,142
-19% -$523K 0.1% 91
2023
Q4
$2.83M Sell
70,485
-29,548
-30% -$1.14M 0.13% 76
2023
Q3
$3.8M Sell
100,033
-2,417
-2% -$95.7K 0.19% 59
2023
Q2
$4.05M Sell
102,450
-3,841
-4% -$151K 0.2% 56
2023
Q1
$4.19M Sell
106,291
-456
-0.4% -$18.1K 0.22% 56
2022
Q4
$4.05M Sell
106,747
-2,882
-3% -$106K 0.21% 57
2022
Q3
$3.82M Sell
109,629
-8,890
-8% -$347K 0.19% 57
2022
Q2
$4.75M Buy
118,519
+13,182
+13% +$553K 0.23% 53
2022
Q1
$4.75M Buy
105,337
+482
+0.5% +$22.7K 0.26% 51
2021
Q4
$5.12M Sell
104,855
-7,510
-7% -$378K 0.27% 49
2021
Q3
$5.66M Sell
112,365
-589
-0.5% -$30.7K 0.33% 36
2021
Q2
$6.23M Buy
112,954
+270
+0.2% +$14.7K 0.35% 34
2021
Q1
$6.01M Buy
112,684
+247
+0.2% +$13.5K 0.38% 31
2020
Q4
$5.81M Buy
112,437
+5,009
+5% +$241K 0.4% 30
2020
Q3
$4.74M Sell
107,428
-991
-0.9% -$43.5K 0.37% 33
2020
Q2
$4.34M Sell
108,419
-9,793
-8% -$367K 0.4% 33
2020
Q1
$4.03M Sell
118,212
-26,087
-18% -$1.07M 0.4% 36
2019
Q4
$6.48M Sell
144,299
-1,959
-1% -$84.1K 0.6% 29
2019
Q3
$5.98M Sell
146,258
-55,485
-28% -$2.29M 0.54% 37
2019
Q2
$8.66M Sell
201,743
-876
-0.4% -$37.2K 0.72% 27
2019
Q1
$8.7M Sell
202,619
-33,117
-14% -$1.39M 0.71% 29
2018
Q4
$9.21M Buy
235,736
+18,515
+9% +$742K 0.7% 30
2018
Q3
$9.32M Sell
217,221
-711
-0.3% -$30.7K 0.8% 28
2018
Q2
$9.44M Buy
217,932
+12,899
+6% +$597K 0.81% 30
2018
Q1
$9.9M Buy
205,033
+85,918
+72% +$4.21M 0.86% 29
2017
Q4
$5.61M Sell
119,115
-87,573
-42% -$4.05M 1.65% 17
2017
Q3
$9.26M Sell
206,688
-2,983
-1% -$131K 0.78% 30
2017
Q2
$8.68M Sell
209,671
-172,927
-45% -$7.04M 0.75% 31
2017
Q1
$10M Sell
382,598
-22,894
-6% -$870K 0.85% 28
2016
Q4
$9.19M Buy
405,492
+200,265
+98% +$7.22M 0.83% 23
2016
Q3
$7.69M Sell
205,227
-11,064
-5% -$404K 0.77% 20
2016
Q2
$7.46M Sell
216,291
-62,655
-22% -$2.1M 0.7% 20
2016
Q1
$9.55M Buy
278,946
+125,534
+82% +$3.89M 0.91% 18
2015
Q4
$4.94M Buy
153,412
+56,350
+58% +$1.93M 0.54% 22
2015
Q3
$3.18M Buy
97,062
+58,813
+154% +$2.08M 0.26% 30
2015
Q2
$1.51M Sell
38,249
-21,562
-36% -$902K 0.15% 36
2015
Q1
$2.4M Sell
59,811
-40
-0.1% -$1.59K 0.31% 26
2014
Q4
$2.35M Buy
59,851
+23,461
+64% +$954K 0.31% 25
2014
Q3
$1.51M Hold
36,390
0.21% 26
2014
Q2
$1.57M Sell
36,390
-6,475
-15% -$275K 0.22% 30
2014
Q1
$1.76M Sell
42,865
-32,733
-43% -$1.28M 0.25% 30
2013
Q4
$3.16M Buy
75,598
+48,109
+175% +$2.01M 0.49% 18
2013
Q3
$1.12M Sell
27,489
-6,538
-19% -$259K 0.2% 23
2013
Q2
$1.31M Buy
+34,027
New +$1.41M 0.21% 29

Other funds holding EEM

Aspiriant LLC's EEM Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 11% in Q1 2026, selling an estimated $260K and leaving 35,362 shares worth $2.01M. The position accounts for 0.06% of the portfolio, ranked #108.

Aspiriant LLC first reported a position in EEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q1 2017. 1,607 funds tracked by Wall St. Rank hold EEM as of Q1 2026.

  • Aspiriant LLC held 35,362 shares of iShares MSCI Emerging Markets ETF worth $2.01M as of Q1 2026.
  • Aspiriant LLC sold 4,418 iShares MSCI Emerging Markets ETF shares in Q1 2026, an estimated $260K.
  • iShares MSCI Emerging Markets ETF made up 0.06% of Aspiriant LLC's portfolio in Q1 2026, its #108 holding.
  • Aspiriant LLC first reported a position in iShares MSCI Emerging Markets ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's iShares MSCI Emerging Markets ETF position peaked at $10M in Q1 2017.
  • 1,607 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.